Jasmien Cornillie

Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors

Yemarshet K. Gebreyohannes, Agnieszka Woźniak, Madalina-Elena Zhai et al. · Clinical Cancer Research · 2018 · 75 citations · Full text

Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification

Jasmien Cornillie, Agnieszka Woźniak, H. Li et al. · Clinical & Translational Oncology · 2019 · 57 citations

Mdm2-tp53 Inhibitor Bi-907828, Mdm2 Amplification, Oncology +8

Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models

Haifu Li, Agnieszka Woźniak, Raf Sciot et al. · Translational Oncology · 2014 · 42 citations · Full text

Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing

Jasmien Cornillie, Agnieszka Woźniak, Haifu Li et al. · Molecular Cancer Therapeutics · 2019 · 38 citations · Full text

Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different <i>KIT</i> Mutations

Yemarshet K. Gebreyohannes, Patrick Schöffski, Thomas Van Looy et al. · Molecular Cancer Therapeutics · 2016 · 31 citations · Full text

Pathology, Tumor Biology, Gastrointestinal Oncology +16